Trends in Mortality Due to Myocardial Infarction, Stroke, and Pulmonary Embolism in Patients Receiving Dialysis
Gürbey Ocak(St. Antonius Ziekenhuis), Anneke Kramer(Amsterdam University Medical Centers), Willem Jan W. Bos(St. Antonius Ziekenhuis), Julia Kerschbaum(Statistics Austria), Emilio Rodrigo(Universidad de Cantabria), Kitty J. Jager(Amsterdam University Medical Centers), Rianne Boenink(GGD Amsterdam), Jaakko Helve(Finnish Cancer Registry), Bjørn Egil Vikse(Privatsykehuset Haugesund), Runólfur Pálsson(Reykjavík University), Lucile Mercadal(Sorbonne Université), Aleix Cases(Hospital Clínico Universitario de Valencia), Ziad A. Massy(Inserm), Mustafa Arıcı, Kristine Hommel(Holbæk Sygehus), Marlies Noordzij(University of Amsterdam), Rafael Santamaría(Instituto de Salud Carlos III), Samira Bell(University of Dundee), Helena Rydell(Karolinska Institutet), Maurizio Nordio(Regione del Veneto), Myrto Kostopoulou(National and Kapodistrian University of Athens), Johan De Meester(AZ Sint-Lucas), Christoph Wanner(Universitätsklinikum Würzburg)
Cited by 11
Related Papers
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913